psychiatric « Science and Enterprise

Trial Shows Results for Depression Drug with Therapy

By Alan, on December 22nd, 2021%

Findings from a clinical trial show an experimental drug helps people in therapy for major depression reduce their symptoms compared to a placebo. . . . → Read More: Trial Shows Results for Depression Drug with Therapy

Trial Shows Psilocybin Drug Helps Reduce Depression

By Alan, on November 10th, 2021%

A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program. . . . → Read More: Trial Shows Psilocybin Drug Helps Reduce Depression

Clinician Guidance App Designed for Depression

By Alan, on October 22nd, 2021%

Neuroscientists and a software company designed a smartphone app to help front-line professionals diagnose and start treatment for patients with depression. . . . → Read More: Clinician Guidance App Designed for Depression

Precision Neuroscience Company Starts-Up, Raises $500M

By Alan, on October 7th, 2021%

A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M

Digital Biofeedback Device Shown to Reduce PTSD

By Alan, on September 9th, 2021%

Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder. . . . → Read More: Digital Biofeedback Device Shown to Reduce PTSD

Biotechs Partner on Agitation Detection Technology

By Alan, on September 2nd, 2021%

Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders. . . . → Read More: Biotechs Partner on Agitation Detection Technology

Psychedelic Therapy Company Raises $80M in New Funds

By Alan, on August 17th, 2021%

A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds

Trial Tests Psychedelic Drug Safety, Chemical Activity

By Alan, on July 28th, 2021%

A clinical trial is underway that tests an hallucinogenic compound among healthy adults as a potential treatment for mental health disorders. . . . → Read More: Trial Tests Psychedelic Drug Safety, Chemical Activity

Trial Underway Testing Suicide-Prevention Nasal Spray

By Alan, on July 6th, 2021%

A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide. . . . → Read More: Trial Underway Testing Suicide-Prevention Nasal Spray

Mental Health Requests Rise During Pandemic

By Alan, on March 4th, 2021%

An analysis of health records shows requests for mental health services increased markedly during the early months of the Covid-19 pandemic. . . . → Read More: Mental Health Requests Rise During Pandemic

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise